Melatonin Could Revolutionize Flap Surgery—Here’s How It Works and What’s Next

Researchers have identified a new mechanism by which melatonin—already a widely used sleep supplement—could prevent tissue death in reconstructive surgeries, according to a study published in Burns & Trauma on February 2, 2026. By blocking a specific type of cell damage called ferroptosis, melatonin improved blood flow and reduced necrosis in skin flaps by up to 30% in animal models, suggesting a potential breakthrough for trauma, burn, and cancer surgery patients.

Why it matters: Every year, over 1 million reconstructive surgeries worldwide rely on skin flaps, but up to 20% fail due to poor blood flow and cell death. This study offers the first clear evidence that melatonin—already FDA-approved for sleep—could be repurposed to protect these critical tissues, cutting costs and improving outcomes.

—

### How Melatonin Stops Tissue Death in Flap Surgery

Skin flaps—tissues surgically moved to repair defects from burns, trauma, or tumor removal—are vulnerable to ischemia (lack of blood flow) and oxidative stress. When blood supply is cut off, cells accumulate iron and lipids that trigger ferroptosis, a form of cell death distinct from apoptosis or necrosis. Unlike traditional antioxidants, melatonin specifically disrupts this pathway by activating the Nrf2/HO-1 signaling pathway, which boosts the body’s natural defenses against oxidative damage.

In lab tests, researchers at Wenzhou Medical University treated human endothelial cells with tert-butyl hydroperoxide (TBHP), a chemical that mimics oxidative injury. Cells given melatonin showed:

• 40% higher viability (cells survived longer)
• 50% reduction in lipid peroxidation (a key marker of ferroptosis)
• Improved tube formation (critical for new blood vessel growth)

“Melatonin isn’t just another antioxidant—it’s targeting the root cause of flap failure,” said Dr. Li Wei, lead author and director of the Oujiang Laboratory. “By blocking ferroptosis, we’re essentially giving ischemic tissue a second chance.”

Did you know? Ferroptosis was only identified in 2012, but recent studies link it to neurodegenerative diseases, cancer, and now surgical complications. Melatonin’s ability to modulate this pathway could extend beyond flaps to other ischemic conditions like stroke or heart attack recovery.

—

### From Mice to Macaques: Real-World Proof of Concept

The study’s findings held across three models:

1. Mice: Flaps treated with melatonin for seven days showed 25% larger viable tissue areas and stronger blood flow signals on laser Doppler scans.
2. Human cells (HUVECs): Melatonin reversed TBHP-induced damage, restoring cell migration and proliferation—key for wound healing.
3. Macaque primates: Oral melatonin reduced necrosis by 30% and improved angiogenesis without adverse effects in blood chemistry tests.

Comparison: Current treatments like hyperbaric oxygen therapy (HBOT) improve flap survival by 10–15%, according to a 2023 meta-analysis in Plastic and Reconstructive Surgery. Melatonin’s 25–30% improvement suggests it could outperform existing methods—but clinical trials are needed to confirm.

Why macaques matter: Their physiology closely mirrors humans, making these results more reliable than rodent studies alone. The lack of side effects in routine blood tests is particularly promising, given melatonin’s established safety profile.

—

### Why This Could Change Surgery Forever

Flap failure isn’t just a medical issue—it’s an economic one. In the U.S. alone, failed reconstructive surgeries cost hospitals $1.2 billion annually in additional procedures and extended recovery, per a 2024 report from the American Society of Plastic Surgeons. Melatonin’s potential to reduce these failures could:

• Cut hospital stays by 2–3 days per patient (saving $10,000+ per case).
• Lower infection rates linked to necrotic tissue.
• Expand flap options for high-risk patients (e.g., diabetics or smokers with poor circulation).

Real-world example: At Mayo Clinic’s burn unit, surgeons already use melatonin off-label to reduce oxidative stress in severe burn patients. Early data suggests it improves graft take rates, but this study provides the first mechanistic explanation for why it works.

Pro Tip: If you’re a surgeon or researcher tracking this, watch for upcoming Phase I trials. The National Institutes of Health lists no active trials on melatonin for flap viability—this study could accelerate that.

—

### The Road Ahead: What’s Next for Melatonin in Surgery?

While the results are promising, key questions remain:

1. Dosage and timing: The study used daily melatonin for seven days, but optimal dosing in humans isn’t clear. A 2025 review in Journal of Pineal Research suggests 5–20 mg/day is safe, but surgical doses may differ.
2. Delivery method: Oral melatonin worked in macaques, but topical or intravenous delivery might be more effective for localized flap protection.
3. Long-term safety: Melatonin’s role in cancer cell growth (it can both promote and inhibit tumors depending on context) needs monitoring in surgical patients.

Expert perspective: “Melatonin’s repurposing for surgery is a perfect example of drug re-positioning,” said Dr. David Greenhalgh, a plastic surgeon at UCLA. “We’ve known it’s safe for decades—now we just need to prove it works in humans at scale.”

Reader Question: “Could melatonin help with other types of tissue damage, like frostbite or radiation burns?”

Answer: Absolutely. Ferroptosis is implicated in both conditions. A 2024 study in Radiation Research found melatonin reduced radiation-induced skin damage in mice by 45%, suggesting broader applications.

—

### FAQ: Melatonin for Flap Surgery—What You Need to Know

1. Is melatonin already used in surgery?

Not yet as a standard treatment, but it’s used off-label in burn units and some cancer surgeries to reduce oxidative stress. This study provides the first evidence for its role in preventing ferroptosis in flaps.

2. How soon could this reach patients?

If Phase I trials begin in 2027 (as some institutions are already planning), FDA approval for flap surgery could take 3–5 years. The biggest hurdle is proving it’s more effective than existing treatments like HBOT.

3. Are there risks to using melatonin in surgery?

Melatonin has an excellent safety profile, but high doses (>50 mg/day) can cause drowsiness. In surgical patients, timing (e.g., avoiding use before anesthesia) would need careful management.

4. Could this work for other types of tissue?

Yes. Ferroptosis is linked to heart attacks, stroke, and neurodegenerative diseases. Early studies suggest melatonin could protect against myocardial infarction (heart attack) damage and Alzheimer’s-related brain cell death.

5. How does this compare to other flap-saving treatments?

Treatment	Effectiveness	Safety	Cost
Hyperbaric Oxygen (HBOT)	10–15% better flap survival	Moderate (risk of oxygen toxicity)	$5,000–$10,000 per session
Vasodilators (e.g., iloprost)	15–20% better survival	High (side effects like hypotension)	$1,000–$3,000 per dose
Melatonin (preclinical)	25–30% better survival	Very high (no major side effects)	$0.50–$2 per dose

Note: Costs are approximate for U.S. healthcare systems.

—

### What This Means for Patients and Doctors

For patients facing flap surgery—whether after a car accident, cancer removal, or severe burn—this study offers hope. “If melatonin pans out, we could see a 30% reduction in flap failures,” says Dr. Wei. “That’s not just better outcomes—it’s fewer surgeries, shorter hospital stays, and less scarring.”

For surgeons, the implications are immediate:

• Melatonin could become a first-line adjuvant in high-risk flap cases.
• Hospitals might adopt it as a low-cost alternative to expensive HBOT chambers.
• Researchers will likely explore topical melatonin gels for localized flap protection.

Call to Action: If you’re a surgeon, stay tuned—early clinical trials may open soon. For patients, this is a reminder that repurposed drugs (like aspirin for heart attacks or Viagra for pulmonary hypertension) often lead to breakthroughs. The next step? Monitor clinical trials and ask your doctor if melatonin could be part of your treatment plan.

Want more? Explore how ferroptosis research is reshaping treatments for cancer and neurodegenerative diseases—or dive into the latest trends in flap surgery.